The latest biotech and pharmaceutical news from BioSpace
The latest biotech and pharmaceutical news from BioSpace
December 23, 2024 · 2 min read · Annalee Armstrong Executive Appointments After Month of Bad News, Applied Shuffles Leadership, Lays Out Uncertain Path for Rare Disease Drug Following a 90% drop in share price due to an FDA rejection and a warning letter over Applied Therapeutics’ conduct...
MEBO Regenerative Medicine News Released in Biospace MEBO Group Release: Life Scientists Were Astounded Again By The Study On "Tissue Organ Regeneration In Situ": Professor Xu, Rong-Xiang Gave A Lecture In The International "Stem Cell And Regenerative Medicine Commercial Implications For The Pharma ...
Image 1: The new Negative-StiffnessCT-1ultra-thin, low-height, low-frequency vibration isolation platform mitigates space constraints in microscopy applications. "Vibration isolation options for microscopy instrumentation like sc anning probe microscopes, interferometers and stylus profilers have been limited...
In The News Contact Us Links Price ListWiley Analytical Science- March 2019What's Minus K delivers Negative-Stiffness tabletop vibration isolation platform Low-height, low-frequency isolator optimizes space in critical microscopy and laboratory applications.Minus K Technology (Minus K) has released its...
BioSpace发布了其2025年最佳工作场所名单。该名单包括50家在美国运营的雇主,其中20家为大型雇主,30家为小型雇主。连续第四年,mRNA领导者Moderna被评为最理想的大型雇主。礼来公司、Regeneron、安进和诺和诺德占据了大型雇主前五名。位于南旧金山的Sutro Biopharma在小型雇主中名列榜首,该公司正在开发多种针对未满足需求的...
Good news for young patients.(PRODUCT SPOTLIGHT: X-ray)(Biospace Medical)(United States. Food and Drug Administration)(Brief article)Valenza, T
San Diego and San Francisco - June 10, 2002 - ChemNavigator and BioSpace have agreed to create integrated access to their Internet-accessible chemical information and clinical development tracking ...San DiegoSan Francisco June
5 Clinical Assets That Flopped in 2024 Cancer Pipelines Shrink as Incyte, iTeos Cut Candidates Following Disappointing Data Roche’s Prothena-Partnered Parkinson’s Drug Fails Mid-Stage Trial Amyloid Hypothesis in Doubt as Newly Approved Drugs Hit Hurdles ...